References
- Drazen JM. Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 1998;158:S193-200
- O’Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997;111(2 Suppl):27-34S
- Lee TH, Woszczek G, Farooque SP. Leukotriene E4: perspective on the forgotten mediator. J Allergy Clin Immunol 2009;124:417-21
- Hallstrand TS, Henderson WR Jr. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 2010;10:60-6
- O’Shaughnessy KM, Taylor IK, O’Connor B, et al. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. Am Rev Respir Dis 1993;147(6 Pt 1):1431-5
- Salvi SS, Krishna MT, Sampson AP, et al. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001;119:1533-46
- Amlani S, Nadarajah T, McIvor RA. Montelukast for the treatment of asthma in the adult population. Expert Opin Pharmacother 2011;12:2119-28
- Wang L, Hollenbeak CS, Mauger DT, et al. Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2011;127:161-6,166.e1
- Gyllfors P, Dahlén SE, Kumlin M, et al. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol 2006;118:78-83
- Wood-Baker R, Town GI, Benning B, et al. The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects. Br J Clin Pharmacol 1995;39:119-23
- Schelfhout V, Van De Velde V, Pauwels R, et al. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma – a comparison with leukotriene D4 induced broncoconstriction. Pulm Pharmacol Ther 2008;21:276-84c
- Smith LJ, Hanby LA, Lavins BJ, et al. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. Ann Allergy Asthma Immunol 1998;81:43-9
- Christie PE, Tagari P, Ford-Hutchinson AW, et al. Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects. Eur Respir J 1994;7:907-13
- Deykin A, Belostotsky O, Hong C, et al. Exhaled nitric oxide following leukotriene E4 and methacholine inhalation in patients with asthma. Am J Respir Crit Care Med 2000;162:1685-9
- O’Shaughnessy TC, Georgiou P, Howland K, et al. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. Thorax 1997;52:519-22
- Casas A, Gómez FP, Dahlén B, et al. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor. Eur Respir J 2005;26:442-8
- Mulder A, Gauvreau GM, Watson RM. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1999;159(5 Pt 1):1562-7
- Gyllfors P, Kumlin M, Dahlén SE, et al. Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis. Thorax 2005;60:902-8
- Adelroth E, Morris MM, Hargreave FE, et al. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986;315(8):480-4
- O'Byrne P, Bateman ED, Bousquet JD, et al. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2009. Available at http://www.ginasthma.org/Guidelines/guidelines-resources.html [Last accessed April 2012]
- Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS task force: standardization of spirometry. Eur Respir J 2005;26:319-38
- Zheng JP, Zhong NS. Normative values of pulmonary function testing in Chinese adults. Chin Med J 2002;115:50-4
- Echazarreta AL, Dahlen B, Garcia G, et al. Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D4 in asthma. Am J Respir Crit Care Med 2001;164:202-6
- Cockcroft DW, Berscheid BA, Murdock KY. Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest 1983;83:751-4
- Gauvreau GM, Parameswaran KN, Watson RM, et al. Inhaled leukotriene E4, but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 2001;164(8 Pt 1):1495-500